ELISA Assay Explained: Principles, Types, and Applications

The enzyme-linked immunosorbent assay (ELISA) is a plate-based immunoassay that detects and quantifies antigens or antibodies in biological samples through enzyme-labelled conjugates and substrates that produce measurable colour changes. ELISA is one of the most specific and straightforward assays for detecting biomolecules in research and clinical diagnostics, and multiple formats now exist to detect various biomarkers. This article explains the core principles of ELISA, compares the four main assay types (direct, indirect, sandwich, and competitive), and provides practical guidance for laboratory professionals selecting and running these assays.

At a Glance: ELISA Format Comparison

Core Principles of ELISA

ELISA detects antigen-antibody interactions by using enzyme-labelled conjugates and enzyme substrates that generate colour changes. The assay depends on the specific binding between an antibody and its target antigen, followed by an enzymatic reaction that converts a substrate into a detectable coloured product. The intensity of the colour correlates with the amount of analyte present in the sample, allowing either qualitative detection or quantitative measurement against a standard curve.

The technique was developed independently and simultaneously by the research groups of Peter Perlmann and Eva Engvall at Stockholm University in Sweden and Anton Schuurs and Bauke van Weemen in The Netherlands. Since the 1970s, fully automated instruments in medical laboratories worldwide have used the immunoassay principle with an enzyme as the reporter label for routine measurement of numerous analytes in patient samples. The impact of EIA and ELISA is reflected in the large number of times these methods have appeared as keywords in the scientific literature since that decade.

All techniques where enzymes are employed to show antigen-antibody reactions are generally referred to as enzymatic immunoassay (EIA) or ELISA methods, since the basic principles of EIA and ELISA are the same. The circulating concentrations of peptides and proteins in biological fluids are influenced by a variety of pathophysiological events, and these concentrations guide clinicians in diagnosing and monitoring diseases. ELISA remains one of the most common methods for measuring these analytes.

Components of an ELISA System

Antibodies and Antigens

The specificity of any ELISA depends on the quality of the antibodies used. Monoclonal antibodies recognize a single epitope and provide high specificity, while polyclonal antibodies recognize multiple epitopes and can offer greater sensitivity through signal amplification. For sandwich formats, the capture and detection antibodies must recognize different epitopes on the target antigen to avoid steric hindrance and ensure accurate detection.

Enzyme Labels and Substrates

Enzymes commonly used as labels include horseradish peroxidase (HRP) and alkaline phosphatase (ALP). These enzymes catalyse reactions with substrates to produce coloured, fluorescent, or chemiluminescent products. The choice of enzyme-substrate pair affects assay sensitivity, dynamic range, and compatibility with detection equipment. Enzyme-immunoassay reliability depends on the enzymes used as labels and the methods applied for conjugate preparation, with possible interferences and detection limits requiring special consideration.

Solid Phases and Immobilization

ELISA typically uses microtiter plates with 96 wells as the solid phase. Antigens or antibodies are immobilized onto the plate surface through passive adsorption or covalent coupling. The efficiency of immobilization affects assay sensitivity and reproducibility. High-affinity avidin-biotin systems can be used for efficient immobilization of DNA fragments or other molecules for further detection by high-specificity antibodies, as described in protocols for detecting 5-hydroxymethylcytosine.

Detection Systems

Colorimetric detection remains the most common readout, where the enzymatic reaction produces a coloured product measured by a plate reader at a specific wavelength. Fluorescent and chemiluminescent detection systems offer increased sensitivity. Nanoparticle-based approaches, particularly gold nanoparticles, have been studied to improve the sensitivity and simplicity of traditional immunoassays due to their facile synthesis, surface functionalization, and superior optical and electronic properties.

Direct ELISA

Direct ELISA was the first ELISA method invented. In this format, an antigen is immobilized directly onto the microtiter plate surface, and an enzyme-labelled primary antibody binds directly to the antigen. After washing away unbound antibody, substrate is added, and the enzymatic reaction produces a measurable signal.

The main advantage of direct ELISA is its simplicity. With fewer steps than other formats, the protocol is shorter and requires fewer reagents. This reduces the potential for error and minimizes assay time. Direct ELISA is useful when screening antibodies for target specificity, as it avoids the need for secondary antibodies that might cross-react with sample components.

The primary limitation is the lack of signal amplification. Because each antigen molecule can bind only one enzyme-labelled antibody, the signal is relatively weak compared to indirect formats. Additionally, every primary antibody must be individually labelled with an enzyme, which is time-consuming and can affect antibody activity. Direct ELISA also carries a higher risk of cross-reactivity because the labelled antibody binds directly to the immobilized antigen without an intermediate amplification step.

Indirect ELISA

Indirect ELISA uses a two-step detection process. An unlabelled primary antibody binds to the immobilized antigen, and then an enzyme-labelled secondary antibody binds to the primary antibody. The secondary antibody is typically raised against the host species of the primary antibody, such as an anti-mouse or anti-rabbit antibody.

The main advantage of indirect ELISA is signal amplification. Multiple secondary antibodies can bind to each primary antibody molecule, increasing the signal and improving sensitivity. This format also eliminates the need to label every primary antibody, since one labelled secondary antibody can be used with many different primary antibodies of the same species.

Indirect ELISA is particularly useful for measuring antibody responses in serum samples. It is commonly used to detect total antibody titres in diagnostic testing and research applications. The format is also valuable when the primary antibody is scarce or expensive, as less antibody is required compared to direct labelling.

The limitations include potential cross-reactivity of the secondary antibody with sample components, particularly if the sample contains antibodies from the same species as the secondary antibody. The additional incubation step also increases the total assay time and introduces more opportunities for variability.

Sandwich ELISA

Sandwich ELISA uses a capture antibody immobilized on the plate to bind the target antigen, followed by a detection antibody that binds a different epitope on the same antigen. This format is called a sandwich because the antigen is held between two antibodies.

The capture antibody is adsorbed onto the plate surface and blocks non-specific binding sites. The sample containing the antigen is added, and the antigen binds to the capture antibody. After washing, a detection antibody is added, which binds to the antigen at a different site from the capture antibody. The detection antibody may be directly enzyme-labelled or detected using a secondary antibody in an indirect sandwich format.

Sandwich ELISA offers high specificity and sensitivity because the antigen must be recognized by two different antibodies. This dual recognition reduces the likelihood of detecting non-specific cross-reactive molecules. The format is well suited for quantifying proteins, peptides, hormones, and cytokines in complex biological fluids such as serum, plasma, and cell culture supernatants.

The main challenge is the requirement for matched antibody pairs that recognize different epitopes on the target antigen. Identifying and validating suitable antibody pairs can be time-consuming and expensive. Sandwich ELISA also requires optimization of capture and detection antibody concentrations to achieve the best signal-to-noise ratio.

An indirect sandwich ELISA protocol using a high-affinity avidin-biotin system has been described for the investigation of 5-hydroxymethylcytosine and TET enzymes. This protocol can be applied to semi-quantitative assays for assessing 5hmC-binding proteins, screening anti-5hmC antibodies, or reading out TET catalytic activity in vitro. A colorimetric enzymatic reaction is developed with intensity correlating with the amount of attached antigen.

Competitive ELISA

Competitive ELISA is designed for detecting small molecules that have only a single epitope and cannot bind two antibodies simultaneously. These molecules include haptens, mycotoxins, drugs, and some hormones.

In competitive ELISA, a limited amount of antibody is used, and the sample antigen competes with a labelled antigen for binding sites. Two variations exist. In one format, the antibody is immobilized on the plate, and a mixture of sample antigen and labelled antigen is added. The sample antigen and labelled antigen compete for the limited antibody binding sites. In another format, the antigen is immobilized on the plate, and sample antigen competes with the immobilized antigen for binding to a limited amount of antibody.

The key feature of competitive ELISA is that the signal is inversely proportional to the concentration of the analyte in the sample. Higher concentrations of sample antigen result in less labelled antigen binding and therefore lower signal. This inverse relationship requires careful data interpretation and standard curve construction.

Competitive ELISA is widely used for detecting mycotoxins in animal feed materials. A competitive ELISA-based origami microfluidic paper analytical device has been developed for rapid detection of three mycotoxins in animal feed materials, demonstrating the practical application of this format in agricultural and veterinary settings.

Nanoparticle-Based and Emerging ELISA Variants

Advances in analytical methods have led to the constant optimization of ELISA to improve sensitivity, and different types of ELISA are now available to detect various biomarkers. Nanoparticle-based ELISA represents one such advancement, using nanoparticles to enhance signal generation and improve detection limits.

Gold nanoparticles have been at the forefront of sensing and detection technologies due to their facile synthesis, surface functionalization, and superior optical and electronic properties. These nanoparticles have been extensively studied to improve the efficacy of immunoassays, including ELISA, PCR, and immuno-PCR assays. Immuno-PCR combines the high specificity of sandwich ELISA with the high sensitivity of PCR for trace detection of biomarkers, though inherent disadvantages limit its application as a rapid and sensitive detection method in clinical settings.

Single-molecule immunoassay technologies represent another emerging approach. Traditional immunological detection techniques such as ELISA and chemiluminescence have detection sensitivities between 10⁻¹⁶ and 10⁻¹² mol/L, which may be inadequate for early diagnosis. Single-molecule immunoassays can reach detection sensitivities of 10⁻¹⁸ mol/L and can detect biomarkers that are difficult to measure using conventional detection techniques. These methods confine molecules to be detected in a small spatial area and provide absolute counting of the detected signal, offering high efficiency and accuracy.

Microarray-based single-molecule immunoassay techniques can test 66 samples in one hour, which is more efficient than conventional immunological detection techniques. Microdroplet-based single-molecule immunoassay techniques can generate 10⁷ droplets in 10 minutes, more than 100 times faster than a single droplet generator. These advances demonstrate the ongoing evolution of immunoassay technology beyond traditional ELISA formats.

Practical ELISA Workflow

Sample Collection and Preparation

Sample quality directly affects ELISA results. Pre-analytical factors including collection method, anticoagulant choice, storage temperature, and freeze-thaw cycles can influence analyte stability and assay performance. Problems encountered during peptide and protein analyses can be classified as pre-analytical, analytical, and post-analytical, and rules should be followed to prevent these problems.

For serum samples, blood should be collected into tubes without anticoagulant and allowed to clot before centrifugation. For plasma samples, the appropriate anticoagulant must be selected based on the analyte of interest. Samples should be processed promptly and stored according to the assay manufacturer recommendations. Repeated freeze-thaw cycles should be avoided, and samples should be aliquoted to prevent degradation.

Plate Preparation and Coating

For direct and indirect ELISA, the antigen is immobilized onto the plate surface through passive adsorption. The coating antigen is diluted in an appropriate buffer and incubated in the wells for a specified time and temperature. After coating, the plate is washed to remove unbound antigen, and blocking buffer is added to saturate remaining protein-binding sites on the plate surface.

For sandwich ELISA, the capture antibody is coated onto the plate instead of the antigen. The capture antibody concentration must be optimized to achieve adequate antigen binding without wasting reagent. Blocking is essential to reduce non-specific binding and background signal.

Incubation and Washing Steps

Each incubation step allows specific binding interactions to occur. Incubation times and temperatures vary depending on the assay format and the reagents used. Optimal conditions should be established during assay development and followed consistently.

Washing between incubation steps removes unbound reagents and reduces background signal. The number of washes and the wash buffer composition affect assay performance. Insufficient washing leads to high background, while excessive washing can reduce specific signal.

Signal Development and Measurement

After the final wash, enzyme substrate is added, and the plate is incubated to allow colour development. The reaction is stopped at the appropriate time by adding stop solution, and the optical density is measured using a plate reader at the appropriate wavelength.

The colour intensity correlates with the amount of analyte present in the sample. For quantitative assays, a standard curve is generated using known concentrations of the analyte, and sample concentrations are interpolated from the curve.

Assay Validation and Quality Control

Standard Curves and Calibration

Quantitative ELISA requires a standard curve generated from known concentrations of the analyte. Standards should be prepared in the same matrix as the samples whenever possible to account for matrix effects. The standard curve should cover the expected range of sample concentrations, and the dynamic range of the assay should be established during validation.

Curve-fitting methods for evaluation of results should be selected based on the assay characteristics. Common approaches include four-parameter logistic and linear regression models. The choice of curve-fitting method affects the accuracy of concentration estimates, particularly at the extremes of the standard curve.

Controls and Replicates

Appropriate controls are essential for valid ELISA results. Positive and negative controls should be included on every plate to monitor assay performance. Blank wells containing all reagents except the sample or standard are used to measure background signal.

Samples and standards should be run in duplicate or triplicate to assess precision. The coefficient of variation between replicates should be monitored, and results exceeding acceptable limits should be investigated.

Method Validation Parameters

Bioanalytical method validation guidance from regulatory authorities outlines the parameters that should be evaluated when validating an ELISA method. These parameters include accuracy, precision, selectivity, sensitivity, reproducibility, and stability. Validation should be performed according to established protocols, and documentation should be maintained to support the reliability of assay results.

The Assay Guidance Manual provides detailed information on developing and validating biochemical and cell-based assays, including ELISA. This resource covers assay design, reagent selection, optimization, and troubleshooting, and is a valuable reference for laboratories developing new ELISA methods.

Records and Documentation

Accurate documentation is essential for ELISA work, particularly in diagnostic and regulated environments. Records should include the assay protocol, reagent lot numbers, sample identification, plate layout, raw optical density readings, standard curve parameters, and calculated concentrations.

The Laboratory Quality Management System Handbook emphasizes the importance of documentation in ensuring the reliability of laboratory results. Quality management systems require that all procedures be documented, records be maintained, and results be traceable to the samples and reagents used.

Laboratory records should also document any deviations from the standard protocol, equipment maintenance and calibration, and corrective actions taken when problems are identified. This documentation supports troubleshooting and provides evidence of assay reliability for audits and inspections.

Common Failure Patterns and Troubleshooting

High Background Signal

High background signal is a common problem in ELISA. This can result from insufficient washing, inadequate blocking, cross-reactivity of secondary antibodies, or contamination of reagents. Troubleshooting steps include increasing the number of washes, optimizing blocking conditions, and verifying antibody specificity.

Low or No Signal

Low or no signal can result from degraded reagents, inactive enzyme labels, incorrect substrate preparation, or failure of antigen immobilization. The problem may also be caused by samples with analyte concentrations below the detection limit of the assay. Troubleshooting includes checking reagent expiration dates, verifying enzyme activity, and confirming that the antigen or capture antibody is properly immobilized.

Poor Reproducibility

Poor reproducibility between replicates or between runs can result from inconsistent pipetting, temperature variations, uneven plate coating, or sample degradation. Standardizing procedures, calibrating pipettes, and monitoring environmental conditions can improve reproducibility.

Hook Effect

The hook effect occurs in sandwich ELISA when very high concentrations of analyte saturate both capture and detection antibodies, resulting in a falsely low signal. This can lead to incorrect quantification of samples with extremely high analyte concentrations. Diluting samples and retesting can identify and correct the hook effect.

Biosafety and Laboratory Practices

ELISA procedures involve handling biological samples that may contain infectious agents. The Laboratory Biosafety Manual provides guidance on safe handling of biological materials, including risk assessment, containment measures, and personal protective equipment.

Laboratory workers should follow standard precautions when handling blood, serum, plasma, and other biological fluids. This includes wearing gloves, laboratory coats, and eye protection, and performing procedures in a manner that minimizes the generation of aerosols.

Waste materials, including used plates, pipette tips, and sample tubes, should be disposed of according to institutional and regulatory requirements. Chemical reagents used in ELISA, including substrates and stop solutions, should be handled according to their safety data sheets.

Applications of ELISA in Research and Diagnostics

Clinical Diagnostics

ELISA is widely used in clinical diagnostics for detecting and quantifying biomarkers in patient samples. The technique is used to measure hormones, tumour markers, cardiac markers, infectious disease antibodies, and autoimmune antibodies. Fully automated instruments in medical laboratories around the world use the immunoassay principle with an enzyme as the reporter label for routine measurements of numerous analytes.

Veterinary and Agricultural Applications

ELISA is used in veterinary diagnostics and agricultural testing. The technique detects pathogens, measures vaccine responses, and monitors animal health. Competitive ELISA is used for detecting mycotoxins in animal feed materials, which is important for ensuring feed safety and preventing mycotoxicosis in livestock.

Research Applications

In research settings, ELISA is used to quantify proteins, peptides, hormones, and cytokines in cell culture supernatants, tissue extracts, and biological fluids. The technique is also used to screen antibodies, characterize antigen-antibody interactions, and measure enzyme activity.

Enzymes purified from biological sources can be used to produce ELISA plates for research purposes. For example, alkaline phosphatase and acetylcholinesterase purified from Moniezia expansa have been characterized and evaluated for potential use in producing enzyme-coated ELISA plates. The purified enzymes displayed specific optimal pH conditions and kinetic properties, and antisera raised against them were effective for determining the enzymes in sera from different animal species.

Food Safety Testing

ELISA is used in food safety testing to detect contaminants, allergens, and adulterants. The technique is applied to detect mycotoxins, veterinary drug residues, and foodborne pathogens. Competitive ELISA formats are particularly useful for detecting small molecule contaminants that cannot be detected using sandwich formats.

Limitations of ELISA

ELISA has several limitations that should be considered when selecting an assay method. The technique requires specific antibodies with high affinity and selectivity, and the quality of antibodies directly affects assay performance. Cross-reactivity with structurally similar molecules can lead to false positive or false negative results.

The detection sensitivity of traditional ELISA may be inadequate for some applications. Detection sensitivities between 10⁻¹⁶ and 10⁻¹² mol/L may not be sufficient for early diagnosis of certain diseases, and more sensitive techniques such as single-molecule immunoassays may be required.

ELISA measures the total concentration of the target analyte but does not provide information about the biological activity of the molecule. For some applications, functional assays may be more appropriate than immunoassays.

Matrix effects can interfere with ELISA results. Components of serum, plasma, or other biological fluids can affect antibody binding or enzyme activity, leading to inaccurate measurements. Matrix effects should be evaluated during assay validation, and appropriate sample preparation or dilution may be required.

Professional Escalation Criteria

Laboratory professionals should escalate issues to supervisors or assay manufacturers when problems cannot be resolved through routine troubleshooting. Escalation is appropriate when:

• Assay performance consistently fails to meet acceptance criteria despite troubleshooting
• Results are inconsistent with clinical findings or expected values
• Reagent quality issues are suspected, such as lot-to-lot variability
• Equipment malfunction is suspected, such as plate reader calibration problems
• New assay validation is required for a new analyte or sample type

When escalating, provide documentation of the problem, troubleshooting steps taken, and relevant data. This information supports effective problem resolution and prevents recurrence.

Frequently Asked Questions

What is the basic principle of ELISA?

ELISA detects antigen-antibody interactions by using enzyme-labelled conjugates and enzyme substrates that generate colour changes. The specific binding between an antibody and its target antigen is followed by an enzymatic reaction that converts a substrate into a detectable coloured product, with the colour intensity correlating with the amount of analyte present.

What are the main types of ELISA?

The four main types of ELISA are direct, indirect, sandwich, and competitive. Direct ELISA uses an enzyme-labelled primary antibody that binds directly to the immobilized antigen. Indirect ELISA uses an unlabelled primary antibody and an enzyme-labelled secondary antibody. Sandwich ELISA uses a capture antibody and a detection antibody that bind different epitopes on the antigen. Competitive ELISA uses a limited amount of antibody and relies on competition between sample antigen and labelled antigen for binding sites.

How do I choose the right ELISA format for my application?

The choice of ELISA format depends on the analyte characteristics and the application. Sandwich ELISA is preferred for quantifying proteins and peptides in complex biological fluids. Competitive ELISA is required for small molecules with a single epitope, such as mycotoxins and drugs. Direct ELISA is useful for simple screening applications, while indirect ELISA is well suited for measuring antibody responses.

What causes high background signal in ELISA?

High background signal can result from insufficient washing, inadequate blocking, cross-reactivity of secondary antibodies, or contamination of reagents. Troubleshooting includes increasing the number of washes, optimizing blocking conditions, and verifying antibody specificity.

What is the hook effect in ELISA?

The hook effect occurs in sandwich ELISA when very high concentrations of analyte saturate both capture and detection antibodies, resulting in a falsely low signal. This can lead to incorrect quantification of samples with extremely high analyte concentrations. Diluting samples and retesting can identify and correct the hook effect.

How should samples be stored for ELISA testing?

Samples should be processed promptly and stored according to the assay manufacturer recommendations. Repeated freeze-thaw cycles should be avoided, and samples should be aliquoted to prevent degradation. The appropriate anticoagulant must be selected for plasma samples based on the analyte of interest.

What is the difference between ELISA and other immunoassay techniques?

ELISA uses an enzyme as the reporter label, while other immunoassay techniques may use fluorescent, chemiluminescent, or radioactive labels. All techniques where enzymes are employed to show antigen-antibody reactions are generally referred to as enzymatic immunoassay or ELISA methods, since the basic principles are the same.

Can ELISA detect small molecules?

Yes, competitive ELISA can detect small molecules that have only a single epitope and cannot bind two antibodies simultaneously. These molecules include haptens, mycotoxins, drugs, and some hormones. The signal in competitive ELISA is inversely proportional to the concentration of the analyte in the sample.

Related Diagnostic Guides

• Comparison of Southern, Northern, and Western Blotting: Principles and Applications
• Nested PCR: Principles, Protocol, and Applications
• Direct vs Indirect Immunofluorescence in Viral Diagnostics
• BCA Assay Protocol: Principles and Step-by-Step Instructions
• Immunofluorescence Assay: Principles and Protocol for Protein Localization

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Enzyme-Linked Immunosorbent Assay (ELISA).. Methods in molecular biology (Clifton, N.J.), 2022.
• An overview of ELISA: a review and update on best laboratory practices for quantifying peptides and proteins in biological fluids.. The Journal of international medical research, 2025.
• A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA.. Peptides, 2015.
• Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA).. Clinical chemistry, 2005.
• Enzyme-immunoassay: a review.. Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 1984.
• ADAMTS13 Activity: Screening Test Protocol.. Methods in molecular biology (Clifton, N.J.), 2023.
• Single-molecule immunoassay technology: Recent advances.. Talanta, 2023.
• Avidin-Biotin ELISA-Based Detection of 5hmC.. Methods in molecular biology (Clifton, N.J.), 2021.
• Transparency in healthcare AI: Testing EU regulatory provisions against users' transparency needs.. 2026.
• Characterization of Muscle Synergies During Activities of Daily Living Using Surface EMG: A Functional Reference for Neuromuscular Assessment.. 2026.
• Variations in the root-soil system influence the grapevine holobiont by shaping plant physiology and root microbiome.. 2026.
• Beyond density: mapping the functional landscapes of macrophage-T lymphocyte niches in the tumor microenvironment.. 2026.
• Isolation, characterization, and ELISA applications of alkaline phosphatase and acetylcholinesterase from Moniezia expansa. Iraqi Journal of Veterinary Sciences, 2024.
• Applications of gold nanoparticles in ELISA, PCR, and immuno-PCR assays: A review.. Analytica Chimica Acta, 2021.
• A cell ELISA based method for exosome detection in diagnostic and therapeutic applications. Biotechnology Letters, 2019.
• Rapid detection of three mycotoxins in animal feed materials using competitive ELISA-based origami microfluidic paper analytical device (μPAD). Analytical and Bioanalytical Chemistry, 2023.
• ELISA METHOD: PRINCIPLE, VARIANTS, AND APPLICATIONS IN BIOMEDICAL RESEARCH. Fiziologichnyi Zhurnal, 2025.
• Nano ELISA system for highly efficient and sensitive molecular recognition. Proceedings of the 11th International Conference on Miniaturized Systems for Chemistry and Life Sciences Utas 2007, 2007.
• Principle and applications of ultra-sensitive ELISA for antigens and antibodies. Japanese Journal of Clinical Chemistry, 2014.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.